Accueil > Publications > High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris 1 janv. 2021European Journal of Immunology DOI : 10.1002/eji.202049058 MembresMAUDE DELOSTIngénieur de recherche OLIVIER LANTZMédecin OLIVIER LANTZMédecin